DAC
Wargo Group Data Access Committee for Neodjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
| Dac ID | Contact Person | Access Information | |
|---|---|---|---|
| EGAC00001001008 | Dr. Nadim Ajami | najami [at] mdanderson [dot] org | No additional information is available |
This DAC controls 2 datasets:
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001004352 | The Whole Exome Sequencing dataset contains 30 whole exome sequencing files (tumor, germ line DNA) and phenotype metadata for 15 patients on the phase II clinical trial of neoadjuvant immune checkpoint blockade in high-risk resectable melanoma at MD Anderson Cancer Center (NCT02519322). Included are data from baseline samples. | Illumina HiSeq 2500 | 30 |
| EGAD00010001608 | The T cell Receptor Sequencing dataset contains 84 files related to T cell receptor sequences obtained using ImmunoSeq by Adaptive Biotechnologies and phenotype metadata from 23 patients enrolled on a phase II clinical trial of neoadjuvant immune checkpoint blockade in high-risk resectable melanoma at MD Anderson Cancer Center (NCT02519322). Included are data on baseline and on-treatment samples from tumor and blood. | MiSeq | 84 |
